31 July 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

31 July 2017 | n=35

  1. McClelland A, French M, Mykhalovskiy E, Gagnon M, et al.
    The harms of HIV criminalization: responding to the 'association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.
    AIDS 2017;31:1899-1900.

  2. Golden MR.
    Assisted partner services for HIV: ready to go global.
    AIDS 2017;31:1891-1893.

  3. Poppe LK, Chunda-Liyoka C, Kwon EH, Gondwe C, et al.
    HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens.
    AIDS 2017;31:1885-1889.

  4. Blaser N, Bertisch B, Kouyos RD, Calmy A, et al.
    Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
    AIDS 2017;31:1859-1866.

  5. Bisson GP, Ramchandani R, Miyahara S, Mngqibisa R, et al.
    Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
    AIDS 2017.

  6. Jan PM, Arora SK.
    Innate Sensing of HIV-1 by Dendritic Cell-Specific ICAM-3 Grabbing Nonintegrin on Dendritic Cells: Degradation and Presentation Versus Transmission of Virus to T Cells Is Determined by Glycan Composition of Viral Envelope.
    AIDS Res Hum Retroviruses 2017.

  7. Shaikh N, Saxena V, Pandey S, Patil A, et al.
    HECT Domain and RCC1-Like Domain-Containing Protein 5 (HERC-5) Gene Polymorphisms in HIV-1-Infected Individuals: A Study from India.
    AIDS Res Hum Retroviruses 2017.

  8. Bengtson AM, Pence BW, Mollan KR, Edwards JK, et al.
    The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care.
    J Acquir Immune Defic Syndr 2017.

  9. Greer AE, Ou SS, Wilson E, Piwowar-Manning E, et al.
    A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.
    J Acquir Immune Defic Syndr 2017.

  10. Braunstein SL, Robbins RS, Daskalakis DC.
    Missed Opportunities: Adapting the HIV Care Continuum to Reduce HIV-related Deaths.
    J Acquir Immune Defic Syndr 2017.

  11. Pittalis S, Orchi N, Carli G, Navarra A, et al.
    HIV self-testing in Italy.
    J Acquir Immune Defic Syndr 2017.

  12. Kunzweiler CP, Bailey RC, Okall DO, Graham SM, et al.
    Factors associated with prevalent HIV infection among Kenyan MSM: The Anza Mapema Study.
    J Acquir Immune Defic Syndr 2017.

  13. Schaffer EM, Agot K, Thirumurthy H.
    The Association between Intimate Partner Violence and Women's Distribution and Use of HIV Self-Tests with Male Partners: Evidence from a Cohort Study in Kenya.
    J Acquir Immune Defic Syndr 2017.

  14. Lodi S, Costagliola D, Sabin C, Amo JD, et al.
    Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.
    J Acquir Immune Defic Syndr 2017.

  15. Husnik MJ, Brown ER, Marzinke M, Livant E, et al.
    Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.
    J Acquir Immune Defic Syndr 2017.

  16. Davey DLJ, M Wall K, Kilembe W, Khu Naw H, et al.
    HIV incidence and predictors of HIV acquisition from an outside partner in serodiscordant couples in Lusaka, Zambia, 1995-2012.
    J Acquir Immune Defic Syndr 2017.

  17. Hraber P, Rademeyer C, Williamson C, Seaman MS, et al.
    Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.
    J Virol 2017.

  18. Schaller T, Bulli L, Pollpeter D, Betancor G, et al.
    Effects of the inner nuclear membrane proteins SUN1/UNC-84A and SUN2/UNC-84B on the early steps of HIV-1 infection.
    J Virol 2017.

  19. Termini JM, Church ES, Silver ZA, Haslam SM, et al.
    HIV and SIV Maintain High Levels of Infectivity in the Complete Absence of Mucin Type O-Glycosylation.
    J Virol 2017.

  20. Boyd MA, Cooper DA.
    Long-acting injectable ART: next revolution in HIV?
    Lancet 2017.

  21. Margolis DA, Gonzalez-Garcia J, Stellbrink HJ, Eron JJ, et al.
    Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
    Lancet 2017.

  22. Hodson N, Bewley S.
    Nelly Mugo and the response to HIV: more than just PrEP advocacy.
    Lancet 2017;390:358.

  23. Green A.
    The HIV response in Ukraine: at a crossroads.
    Lancet 2017;390:347-348.

  24. Beyrer C, Das P, Horton R, Ryan O, et al.
    The International AIDS Society-Lancet Commission on the future of the HIV response and global health.
    Lancet 2017;390:344-345.

  25. Granich R, Williams B, Montaner J, Zuniga JM, et al.
    90-90-90 and ending AIDS: necessary and feasible.
    Lancet 2017;390:341-343.

  26. The Lancet.
    The global HIV/AIDS epidemic-progress and challenges.
    Lancet 2017;390:333.

  27. Hall EW, Morris SB, Moore BK, Erasmus L, et al.
    Treatment Outcomes of Children with HIV Infection and Drug-Resistant TB in Three Provinces in South Africa, 2005-2008.
    Pediatr Infect Dis J 2017.

  28. Coker M, El-Kamary S, Enwonwu C, Blattner W, et al.
    Perinatal HIV Infection and Exposure and their Association with Dental Caries in Nigerian Children.
    Pediatr Infect Dis J 2017.

  29. Dabis F, Bekker LG.
    We still need to beat HIV.
    Science 2017.

  30. Vancoillie L, Hebberecht L, Dauwe K, Demecheleer E, et al.
    Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus.
    Virology 2017;510:185-193.

  31. Schmitt K, Mohan Kumar D, Curlin J, Remling-Mulder L, et al.
    Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice.
    Virology 2017;510:175-184.

  32. Cousins S.
    HIV agenda must be prioritised to reduce deaths from AIDS in sub-Saharan Africa.
    BMJ 2017;358:j3638.

  33. Cousins S.
    PrEP on demand reduces HIV infections, study finds.
    BMJ 2017;358:j3619.

  34. Cousins S.
    Child treated for HIV in infancy has been healthy for nine years.
    BMJ 2017;358:j3587.

  35. Cousins S.
    Number of new HIV infections is rising in Russia.
    BMJ 2017;358:j3543.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

16 July 2018

09 July 2018

02 July 2018

25 June 2018

18 June 2018

31 July 2017

Multidisciplinary Journal Club

    No data available 2017-07-31.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016